Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L MICHAUX

Showing results (131-140 of 230) with videos related to

Pageof 23
Sort By:
Leukemia|October 1, 1995
A new t(2;5) translocation in a null cell type CD30 positive anaplastic large cell lymphoma caseI Wlodarska, C De Wolf-Peeters, L Michaux, et al.
Cancer Genetics and Cytogenetics|June 1, 1984
Translocation t(3;17)(q26;q22): a marker of acute disease in myeloproliferative disorders?C Mecucci, J L Michaux, A Broeckaert-Van Orshoven, et al.
Journal of the National Cancer Institute|July 1, 1979
Philadelphia chromosome in human multiple myelomaH Van Den Berghe, A Louwagie, A Broeckaert-Van Orshoven, et al.
Leukemia & Lymphoma|May 1, 1996
Limited activity of mini-dose interferon alpha-2a in the treatment of myelodysplastic syndromeM Maerevoet, E Van Den Neste, A Delannoy, et al.
Cancer Genetics and Cytogenetics|July 21, 2001
Trisomy 16 as the sole anomaly in hematological malignancies. Three new cases and a short reviewB Guillaume, G Ameye, J Dierlamm, et al.
Archives of Disease in Childhood|October 1, 1991
Bone marrow transplantation in sickle cell anaemiaC Vermylen, G Cornu, M Philippe, et al.
Hematological Oncology|May 8, 2000
Genetic abnormalities in marginal zone B-cell lymphomaJ Dierlamm, I Wlodarska, L Michaux, et al.
European Journal of Haematology|November 15, 2002
Epstein-Barr virus-associated lymphoproliferative disease occurring in a patient with sarcoidosis treated by methotrexate and methylprednisoloneI Theate, L Michaux, S Dardenne, et al.
Leukemia|August 23, 2001
Atypical lymphocytic leukemia and mantle cell lymphoma immunologically very close: flow cytometric distinction by the use of CD20 and CD54 expressionV Deneys, L Michaux, P Leveugle, et al.
Leukemia|July 1, 1995
2-Chlorodeoxyadenosine (CdA) for patients with previously untreated chronic lymphocytic leukemia (CLL)A Delannoy, P Martiat, J L Gala, et al.
Pageof 23

Showing results (131-140 of 230) with videos related to

Sort By:
Pageof 23
Leukemia|October 1, 1995
A new t(2;5) translocation in a null cell type CD30 positive anaplastic large cell lymphoma caseI Wlodarska, C De Wolf-Peeters, L Michaux, et al.
Cancer Genetics and Cytogenetics|June 1, 1984
Translocation t(3;17)(q26;q22): a marker of acute disease in myeloproliferative disorders?C Mecucci, J L Michaux, A Broeckaert-Van Orshoven, et al.
Journal of the National Cancer Institute|July 1, 1979
Philadelphia chromosome in human multiple myelomaH Van Den Berghe, A Louwagie, A Broeckaert-Van Orshoven, et al.
Leukemia & Lymphoma|May 1, 1996
Limited activity of mini-dose interferon alpha-2a in the treatment of myelodysplastic syndromeM Maerevoet, E Van Den Neste, A Delannoy, et al.
Cancer Genetics and Cytogenetics|July 21, 2001
Trisomy 16 as the sole anomaly in hematological malignancies. Three new cases and a short reviewB Guillaume, G Ameye, J Dierlamm, et al.
Archives of Disease in Childhood|October 1, 1991
Bone marrow transplantation in sickle cell anaemiaC Vermylen, G Cornu, M Philippe, et al.
Hematological Oncology|May 8, 2000
Genetic abnormalities in marginal zone B-cell lymphomaJ Dierlamm, I Wlodarska, L Michaux, et al.
European Journal of Haematology|November 15, 2002
Epstein-Barr virus-associated lymphoproliferative disease occurring in a patient with sarcoidosis treated by methotrexate and methylprednisoloneI Theate, L Michaux, S Dardenne, et al.
Leukemia|August 23, 2001
Atypical lymphocytic leukemia and mantle cell lymphoma immunologically very close: flow cytometric distinction by the use of CD20 and CD54 expressionV Deneys, L Michaux, P Leveugle, et al.
Leukemia|July 1, 1995
2-Chlorodeoxyadenosine (CdA) for patients with previously untreated chronic lymphocytic leukemia (CLL)A Delannoy, P Martiat, J L Gala, et al.
Pageof 23